Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Study With Tocilizumab in Combination With Venetoclax and Azacitidine Chemotherapy in Patients With Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial updating on the use of tocilizumab in combination with venetoclax and azacitidine for acute myeloid leukemia; the study is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZACITIDINE (AZACITIDINE)
  • Tocilizumab (tocilizumab)
  • Venetoclax (venetoclax)

Snippet

Sponsor: Nantes University Hospital | Conditions: Leukemia Acute Myeloid - AML | Phase 1 | Status: NOT_YET_RECRUITING